Financhill
Back

PAVmed Quote, Financials, Valuation and Earnings

PAVmed Price Quote

$0.61
+0.02 (+0.81%)
(Updated: December 21, 2024 at 5:41 AM ET)

PAVmed Key Stats

Sell
15
PAVmed (PAVM) is a Sell

Day range:
$0.59 - $0.64
52-week range:
$0.59 - $4.29
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.58
P/B ratio:
0%

Volume:
72.7K
Avg. volume:
107K
1-year change:
-81.58%
Market cap:
$6.6M
Revenue:
$2.5M
EPS:
$-4.3

How Much Does PAVmed Make?

Data Unavailable

Is PAVmed Growing As A Company?

Data Unavailable

PAVmed Stock Price Performance

  • Did PAVmed Stock Go Up Last Month?
    PAVmed share price went down by -42.46% last month
  • Did PAVM's Share Price Rise Over The Last Year?
    PAVM share price fell by -81.58% over the past 1 year

What Is PAVmed 52-Week High & Low?

  • What Is PAVmed’s 52-Week High Share Price?
    PAVmed has traded as high as $4.29 over the past 52 weeks
  • What Is PAVmed’s 52-Week Low Share Price?
    PAVmed has traded as low as $0.59 over the past 52 weeks

PAVmed Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PAVmed?

Data Unavailable

Is PAVmed Cash Flow Positive?

Data Unavailable

PAVmed Return On Invested Capital

Data Unavailable

PAVmed Earnings Date & Stock Price

  • What Is PAVmed's Stock Price Today?
    A single share of PAVM can be purchased today for 0.59
  • What Is PAVmed’s Stock Symbol?
    PAVmed trades on the nasdaq under the ticker symbol: PAVM
  • When Is PAVmed’s Next Earnings Date?
    The next quarterly earnings date for PAVmed is scheduled on March 27, 2025
  • When Is PAVM's next ex-dividend date?
    PAVmed's next ex-dividend date is December 22, 2024
  • How To Buy PAVmed Stock?
    You can buy PAVmed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

PAVmed Competitors

  • Who Are PAVmed's Competitors?
    Below is a list of companies who compete with PAVmed or are related in some way:
    • Cutera Inc (CUTR)
    • Electromed Inc (ELMD)
    • IRIDEX Corp (IRIX)
    • Myomo Inc (MYO)
    • Stereotaxis Inc (STXS)

PAVmed Dividend Yield

Data Unavailable

PAVmed Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 58.46%
Revenue: 25.92% -8.9%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable